| |
| |
|
| Insider
Information: |
Gluck Frederick W |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
254,591 |
|
|
Indirect Shares
|
271,643 |
|
|
| Direct
Value |
$5,451,196 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
526,234 |
|
|
| Total
Value |
$5,451,196 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
HCA Holdings Inc |
HCA |
Director |
2006-11-17 |
0 |
2003-08-08 |
0 |
Premium* |
|
|
Amgen Inc |
AMGN |
Director |
2011-04-25 |
17,576 |
2004-03-15 |
0 |
Premium* |
|
|
Cytomx Therapeutics, Inc. |
CTMX |
Director |
2019-04-08 |
237,015 |
2019-04-08 |
271,643 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
35 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HCA |
HCA Holdings Inc |
Director |
– • – |
2003-08-08 |
4 |
A |
$36.95 |
$70,020 |
D/D |
1,895 |
15,933 |
|
- |
|
| AMGN |
Amgen Inc |
Director |
– • – |
2004-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,643 |
1,643 |
|
- |
|
| HCA |
HCA Holdings Inc |
Director |
– • – |
2004-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,900 |
17,833 |
|
- |
|
| AMGN |
Amgen Inc |
Director |
– • – |
2005-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,706 |
1,706 |
|
- |
|
| HCA |
HCA Holdings Inc |
Director |
– • – |
2005-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,623 |
19,456 |
|
- |
|
| AMGN |
Amgen Inc |
Director |
– • – |
2005-12-28 |
5 |
GD |
$0.00 |
$0 |
D/D |
4,705 |
3,644 |
0 |
- |
|
| AMGN |
Amgen Inc |
Director |
– • – |
2006-02-17 |
4 |
B |
$74.48 |
$350,427 |
D/D |
4,705 |
8,349 |
2.39 |
- |
|
| AMGN |
Amgen Inc |
Director |
– • – |
2006-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,335 |
9,684 |
0 |
- |
|
| HCA |
HCA Holdings Inc |
Director |
– • – |
2006-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
3,191 |
22,647 |
|
- |
|
| HCA |
HCA Holdings Inc |
Director |
– • – |
2006-11-17 |
4 |
D |
$51.00 |
$1,154,997 |
D/D |
(22,647) |
0 |
0 |
- |
|
| AMGN |
Amgen Inc |
Director |
– • – |
2007-04-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,598 |
11,282 |
0 |
- |
|
| AMGN |
Amgen Inc |
Director |
– • – |
2008-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
2,373 |
13,655 |
0 |
- |
|
| AMGN |
Amgen Inc |
Director |
– • – |
2009-01-27 |
4 |
OE |
$28.97 |
$463,501 |
D/D |
16,000 |
29,655 |
0 |
- |
|
| AMGN |
Amgen Inc |
Director |
– • – |
2009-01-27 |
4 |
S |
$53.25 |
$852,610 |
D/D |
(16,000) |
13,655 |
0 |
- |
|
| AMGN |
Amgen Inc |
Director |
– • – |
2009-04-28 |
4 |
A |
$0.00 |
$0 |
D/D |
1,982 |
1,982 |
0 |
- |
|
| AMGN |
Amgen Inc |
Director |
– • – |
2010-04-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,711 |
17,348 |
0 |
- |
|
| AMGN |
Amgen Inc |
Director |
– • – |
2010-08-26 |
4 |
S |
$51.76 |
$41,404 |
D/D |
(800) |
16,548 |
0 |
- |
|
| AMGN |
Amgen Inc |
Director |
– • – |
2010-09-08 |
4 |
S |
$52.36 |
$41,888 |
D/D |
(800) |
15,748 |
0 |
- |
|
| AMGN |
Amgen Inc |
Director |
– • – |
2011-04-25 |
4 |
A |
$0.00 |
$0 |
D/D |
1,828 |
17,576 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Director |
– • – |
2015-10-14 |
4 |
B |
$12.00 |
$120,000 |
D/D |
10,000 |
147,791 |
2.39 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Director |
– • – |
2015-10-14 |
4 |
B |
$12.00 |
$60,000 |
I/I |
5,000 |
5,000 |
2.1 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
|
• • – |
2016-04-05 |
4 |
A |
$0.00 |
$0 |
I/I |
348,754 |
22,111 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Director |
– • – |
2016-08-09 |
4 |
OE |
$0.95 |
$118,709 |
D/D |
93,124 |
240,915 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Director |
– • – |
2017-06-26 |
4 |
AS |
$14.61 |
$73,050 |
I/I |
(5,000) |
326,643 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Director |
– • – |
2017-09-26 |
4 |
AS |
$17.30 |
$86,476 |
I/I |
(5,000) |
321,643 |
0 |
- |
|
35 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
